ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Measles, Mumps and Rubella (MMR) Vaccines Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-12S10072
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Measles Mumps and Rubella MMR Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Global Measles, Mumps and Rubella (MMR) Vaccines Market Research Report 2025

Code: QYRE-Auto-12S10072
Report
July 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Medlmmune
Johnson & Johnson
Merck
Sanofi
Serum
Bavarian Nordic
Astellas Pharma
Emergent Biosolutions
GlaxoSmithKline PLC
Pfizer Inc
CSL Limited
Johnson & Johnson

Measles, Mumps and Rubella (MMR) Vaccines Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Measles, Mumps and Rubella (MMR) Vaccines Market

Measles, Mumps and Rubella (MMR) Vaccines Market

The global market for Measles, Mumps and Rubella (MMR) Vaccines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Measles can lead to otitis media, tracheitis, encephalitis and other complications.Mumps can cause hearing loss and inflammation of the ovaries or testes.German measles can lead to arthritis, encephalitis, conjunctivitis, miscarriage or birth defects.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Measles, Mumps and Rubella (MMR) Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles, Mumps and Rubella (MMR) Vaccines.
The Measles, Mumps and Rubella (MMR) Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Measles, Mumps and Rubella (MMR) Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Measles, Mumps and Rubella (MMR) Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Measles, Mumps and Rubella (MMR) Vaccines Market Report

Report Metric Details
Report Name Measles, Mumps and Rubella (MMR) Vaccines Market
CAGR 5%
Segment by Type
Segment by Application
  • Immune Center
  • Vaccine Development Agencies and Organizations
  • Hospital
  • Laboratory
  • Biotechnology and Biopharmaceutical Companies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medlmmune, Johnson & Johnson, Merck, Sanofi, Serum, Bavarian Nordic, Astellas Pharma, Emergent BioSolutions, GlaxoSmithKline, Pfizer, CSL
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Measles, Mumps and Rubella (MMR) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Measles, Mumps and Rubella (MMR) Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Measles, Mumps and Rubella (MMR) Vaccines Market report?

Ans: The main players in the Measles, Mumps and Rubella (MMR) Vaccines Market are Medlmmune, Johnson & Johnson, Merck, Sanofi, Serum, Bavarian Nordic, Astellas Pharma, Emergent BioSolutions, GlaxoSmithKline, Pfizer, CSL

What are the Application segmentation covered in the Measles, Mumps and Rubella (MMR) Vaccines Market report?

Ans: The Applications covered in the Measles, Mumps and Rubella (MMR) Vaccines Market report are Immune Center, Vaccine Development Agencies and Organizations, Hospital, Laboratory, Biotechnology and Biopharmaceutical Companies

What are the Type segmentation covered in the Measles, Mumps and Rubella (MMR) Vaccines Market report?

Ans: The Types covered in the Measles, Mumps and Rubella (MMR) Vaccines Market report are Monovalent Vaccine, Polyvalent Vaccine

Recommended Reports

Human Vaccines

Vaccine Technology

Multivalent & Novel Vaccines

1 Measles, Mumps and Rubella (MMR) Vaccines Market Overview
1.1 Product Definition
1.2 Measles, Mumps and Rubella (MMR) Vaccines by Type
1.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monovalent Vaccine
1.2.3 Polyvalent Vaccine
1.3 Measles, Mumps and Rubella (MMR) Vaccines by Application
1.3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Immune Center
1.3.3 Vaccine Development Agencies and Organizations
1.3.4 Hospital
1.3.5 Laboratory
1.3.6 Biotechnology and Biopharmaceutical Companies
1.4 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Estimates and Forecasts
1.4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue 2020-2031
1.4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales 2020-2031
1.4.3 Global Measles, Mumps and Rubella (MMR) Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Measles, Mumps and Rubella (MMR) Vaccines Market Competition by Manufacturers
2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Measles, Mumps and Rubella (MMR) Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Measles, Mumps and Rubella (MMR) Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Measles, Mumps and Rubella (MMR) Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Measles, Mumps and Rubella (MMR) Vaccines, Date of Enter into This Industry
2.8 Global Measles, Mumps and Rubella (MMR) Vaccines Market Competitive Situation and Trends
2.8.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Measles, Mumps and Rubella (MMR) Vaccines Players Market Share by Revenue
2.8.3 Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Measles, Mumps and Rubella (MMR) Vaccines Market Scenario by Region
3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region: 2020-2031
3.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region: 2020-2025
3.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region: 2026-2031
3.3 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region: 2020-2031
3.3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region: 2020-2025
3.3.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region: 2026-2031
3.4 North America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country
3.4.1 North America Measles, Mumps and Rubella (MMR) Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2020-2031)
3.4.3 North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country
3.5.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2020-2031)
3.5.3 Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country
3.7.1 Latin America Measles, Mumps and Rubella (MMR) Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2020-2031)
4.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2020-2025)
4.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2026-2031)
4.1.3 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2020-2031)
4.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2020-2025)
4.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2026-2031)
4.2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2020-2031)
5.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2020-2025)
5.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2026-2031)
5.1.3 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2020-2031)
5.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2020-2025)
5.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2026-2031)
5.2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medlmmune
6.1.1 Medlmmune Company Information
6.1.2 Medlmmune Description and Business Overview
6.1.3 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.1.5 Medlmmune Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Company Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Serum
6.5.1 Serum Company Information
6.5.2 Serum Description and Business Overview
6.5.3 Serum Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Serum Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.5.5 Serum Recent Developments/Updates
6.6 Bavarian Nordic
6.6.1 Bavarian Nordic Company Information
6.6.2 Bavarian Nordic Description and Business Overview
6.6.3 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.6.5 Bavarian Nordic Recent Developments/Updates
6.7 Astellas Pharma
6.7.1 Astellas Pharma Company Information
6.7.2 Astellas Pharma Description and Business Overview
6.7.3 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.7.5 Astellas Pharma Recent Developments/Updates
6.8 Emergent BioSolutions
6.8.1 Emergent BioSolutions Company Information
6.8.2 Emergent BioSolutions Description and Business Overview
6.8.3 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.8.5 Emergent BioSolutions Recent Developments/Updates
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Company Information
6.9.2 GlaxoSmithKline Description and Business Overview
6.9.3 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.9.5 GlaxoSmithKline Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Company Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 CSL
6.11.1 CSL Company Information
6.11.2 CSL Description and Business Overview
6.11.3 CSL Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 CSL Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.11.5 CSL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Measles, Mumps and Rubella (MMR) Vaccines Industry Chain Analysis
7.2 Measles, Mumps and Rubella (MMR) Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Measles, Mumps and Rubella (MMR) Vaccines Production Mode & Process Analysis
7.4 Measles, Mumps and Rubella (MMR) Vaccines Sales and Marketing
7.4.1 Measles, Mumps and Rubella (MMR) Vaccines Sales Channels
7.4.2 Measles, Mumps and Rubella (MMR) Vaccines Distributors
7.5 Measles, Mumps and Rubella (MMR) Vaccines Customer Analysis
8 Measles, Mumps and Rubella (MMR) Vaccines Market Dynamics
8.1 Measles, Mumps and Rubella (MMR) Vaccines Industry Trends
8.2 Measles, Mumps and Rubella (MMR) Vaccines Market Drivers
8.3 Measles, Mumps and Rubella (MMR) Vaccines Market Challenges
8.4 Measles, Mumps and Rubella (MMR) Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Medlmmune
Johnson & Johnson
Merck
Sanofi
Serum
Bavarian Nordic
Astellas Pharma
Emergent Biosolutions
GlaxoSmithKline PLC
Pfizer Inc
CSL Limited
Johnson & Johnson
List of Tables
 Table 1. Global Measles, Mumps and Rubella (MMR) Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Measles, Mumps and Rubella (MMR) Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Measles, Mumps and Rubella (MMR) Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Measles, Mumps and Rubella (MMR) Vaccines Average Price (USD/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Measles, Mumps and Rubella (MMR) Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Measles, Mumps and Rubella (MMR) Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Measles, Mumps and Rubella (MMR) Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Measles, Mumps and Rubella (MMR) Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Measles, Mumps and Rubella (MMR) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles, Mumps and Rubella (MMR) Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2020-2025) & (K Doses)
 Table 18. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2026-2031) & (K Doses)
 Table 20. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2020-2025) & (K Doses)
 Table 27. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2026-2031) & (K Doses)
 Table 28. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2020-2025) & (K Doses)
 Table 32. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2026-2031) & (K Doses)
 Table 33. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2020-2025) & (K Doses)
 Table 37. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2026-2031) & (K Doses)
 Table 38. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2020-2025) & (K Doses)
 Table 42. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2026-2031) & (K Doses)
 Table 43. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2020-2025) & (K Doses)
 Table 47. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2026-2031) & (K Doses)
 Table 48. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2020-2025)
 Table 51. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2026-2031)
 Table 52. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Type (2020-2025)
 Table 59. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Type (2026-2031)
 Table 60. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2020-2025)
 Table 61. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2026-2031)
 Table 62. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Application (2020-2025)
 Table 69. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Application (2026-2031)
 Table 70. Medlmmune Company Information
 Table 71. Medlmmune Description and Business Overview
 Table 72. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 73. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product
 Table 74. Medlmmune Recent Developments/Updates
 Table 75. Johnson & Johnson Company Information
 Table 76. Johnson & Johnson Description and Business Overview
 Table 77. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 78. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Product
 Table 79. Johnson & Johnson Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 83. Merck Measles, Mumps and Rubella (MMR) Vaccines Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Sanofi Company Information
 Table 86. Sanofi Description and Business Overview
 Table 87. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 88. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Product
 Table 89. Sanofi Recent Developments/Updates
 Table 90. Serum Company Information
 Table 91. Serum Description and Business Overview
 Table 92. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 93. Serum Measles, Mumps and Rubella (MMR) Vaccines Product
 Table 94. Serum Recent Developments/Updates
 Table 95. Bavarian Nordic Company Information
 Table 96. Bavarian Nordic Description and Business Overview
 Table 97. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 98. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Product
 Table 99. Bavarian Nordic Recent Developments/Updates
 Table 100. Astellas Pharma Company Information
 Table 101. Astellas Pharma Description and Business Overview
 Table 102. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 103. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Product
 Table 104. Astellas Pharma Recent Developments/Updates
 Table 105. Emergent BioSolutions Company Information
 Table 106. Emergent BioSolutions Description and Business Overview
 Table 107. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 108. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Product
 Table 109. Emergent BioSolutions Recent Developments/Updates
 Table 110. GlaxoSmithKline Company Information
 Table 111. GlaxoSmithKline Description and Business Overview
 Table 112. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 113. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Product
 Table 114. GlaxoSmithKline Recent Developments/Updates
 Table 115. Pfizer Company Information
 Table 116. Pfizer Description and Business Overview
 Table 117. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 118. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Product
 Table 119. Pfizer Recent Developments/Updates
 Table 120. CSL Company Information
 Table 121. CSL Description and Business Overview
 Table 122. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 123. CSL Measles, Mumps and Rubella (MMR) Vaccines Product
 Table 124. CSL Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Measles, Mumps and Rubella (MMR) Vaccines Distributors List
 Table 128. Measles, Mumps and Rubella (MMR) Vaccines Customers List
 Table 129. Measles, Mumps and Rubella (MMR) Vaccines Market Trends
 Table 130. Measles, Mumps and Rubella (MMR) Vaccines Market Drivers
 Table 131. Measles, Mumps and Rubella (MMR) Vaccines Market Challenges
 Table 132. Measles, Mumps and Rubella (MMR) Vaccines Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Measles, Mumps and Rubella (MMR) Vaccines
 Figure 2. Global Measles, Mumps and Rubella (MMR) Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Type: 2024 & 2031
 Figure 4. Monovalent Vaccine Product Picture
 Figure 5. Polyvalent Vaccine Product Picture
 Figure 6. Global Measles, Mumps and Rubella (MMR) Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Application: 2024 & 2031
 Figure 8. Immune Center
 Figure 9. Vaccine Development Agencies and Organizations
 Figure 10. Hospital
 Figure 11. Laboratory
 Figure 12. Biotechnology and Biopharmaceutical Companies
 Figure 13. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (2020-2031) & (K Doses)
 Figure 16. Global Measles, Mumps and Rubella (MMR) Vaccines Average Price (USD/Dose) & (2020-2031)
 Figure 17. Measles, Mumps and Rubella (MMR) Vaccines Report Years Considered
 Figure 18. Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Manufacturers in 2024
 Figure 19. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Measles, Mumps and Rubella (MMR) Vaccines Players: Market Share by Revenue in Measles, Mumps and Rubella (MMR) Vaccines in 2024
 Figure 21. Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2020-2031)
 Figure 24. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2020-2031)
 Figure 28. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2020-2031)
 Figure 36. China Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Type (2020-2031)
 Figure 58. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Application (2020-2031)
 Figure 61. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Application (2020-2031)
 Figure 62. Measles, Mumps and Rubella (MMR) Vaccines Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Measles Mumps and Rubella Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Measles Mumps Rubella and Varicella Combined Vaccine Market Research Report 2024
Global Measles and Rubella Vaccine Market Research Report 2025
Global Measles and Rubella MR Vaccine Market Research Report 2025
Global Measles and Rubella Vaccines Market Research Report 2025
Global Mumps Vaccine Market Research Report 2025
Measles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccines For Children Market Insights Forecast to 2030
Global Live Attenuated Measles Vaccine Market Research Report 2025
Global Measle Vaccine Market Research Report 2025
Global Measles Combined with Live Attenuated Vaccine Market Research Report 2025
Global Mumps Drug Market Research Report 2025
Respiratory Syncytial Virus Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccines for the Elderly Market Research Report 2024
Meningococcal Disease Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pediatric Respiratory Syncytial Virus Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Respiratory Syncytial Virus Vaccine for Children Market Research Report 2024
Global Multiple Vaccine Market Research Report 2024
Paediatric Vaccine Market
Global Seasonal Vaccines Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions